v3.26.1
Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2026
Fair Value Disclosures [Abstract]  
Schedule of Financial Liabilities Measured at Fair Value on Recurring Basis by Level Within Fair Value Hierarchy

 

   Fair Value Measurements as of June 30, 2026 
Description  Level 1   Level 2   Level 3   Total 
Derivative liabilities:                    
Common stock warrants  $-   $-   $345   $345 

 

   Fair Value Measurements as of December 31, 2025 
Description  Level 1   Level 2   Level 3   Total 
Derivative liabilities:                    
Common stock warrants  $-   $-   $827   $827 
Schedule of Fair Value Measurement Hierarchy of Derivative Liability

The Company did not have any transfers of assets and liabilities between Level 1 and Level 2 of the fair value measurement hierarchy during the six months ended June 30, 2026, and 2025. The following table presents a reconciliation of the derivative liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the six months ended June 30, 2026, and 2025 (in thousands):

 

  

Common Stock

Warrants

 
Balance as of December 31, 2024  $208 
Change in fair value   (48)
Balance as of June 30, 2025  $160 
      
Balance as of December 31, 2025  $827 
Change in fair value   (482)
Balance as of June 30, 2026  $345 
Schedule of Assumptions Used in Estimating Fair Value

The assumptions used in estimating the common stock warrant liability using the Monte Carlo simulation valuation model as of June 30, 2026, and December 31, 2025 were as follows:

 

    

June 30,

2026

    

December 31,

2025

 
Weighted-average risk-free interest rate   4.03-4.17%   3.42-3.65%
Weighted-average expected life (in years)   1.30-3.98     0.11-4.48  
Expected dividend yield   -%   -%
Weighted-average expected volatility   90.00-155.00%   115.00-175.00%